1. Office of Technology Assessment. Recombinant human erythropoietin: Payment options for Medicare. Publication No. OTA-H-451. Washington, DC: United States Government Printing Office, 1990
2. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J1990; 300: 573–578
3. Raeburn JM, Rootman I. Quality of life and health promotion. In: Renwick R, Brown I, Nagler M, eds. Quality of Life in Health Promotion and Rehabilitation. Sage Publications, Thousand Oaks, 1996; 14–25
4. Felce D. Defining and applying the concept of quality of life. J Intellect Disabil Res1997; 41: 126–135
5. World Health Organization. Constitution in Basic Documents WHO, Geneva, 1948